首页 > 资讯
Nasdaq Stockholm Streamlines Dual Listing Process for US-Listed Companies to access European markets
2024-12-03 资讯 NasdaqSTOCKHOLM, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today an update to the Nasdaq Stockholm Main Market rulebook, effective from 1 January 2025. This update will streamline the listing review process for companies seeking to list on Nasdaq Stockholm simultaneously with or within 12 months of a listing on the U.S. exchanges, including the Nasdaq Stock Exchange and the New York Stock Exchange.
As the first of several listing simplification initiatives, Nasdaq Europe is focused on driving capital markets integration and leading the development of EU capital markets and listing environment.
Currently, the dual listing process is largely conducted independently in the US and Sweden, resulting in the duplication of time and resource-intensive tasks. Under the new model, companies approved to list in the US will still be reviewed through the Nasdaq Stockholm listing process but will no longer require a separate review by a listing auditor when applying for a dual listing on Nasdaq Stockholm. This task, associated with costs and efforts, is redundant for a company that has already been validated according to standards that are equivalent or similar.
Adam Kostyál, President of Nasdaq Stockholm, stated, “Simplifying the process for European companies to dual list in the US and Europe represents a significant milestone in our ability to strengthen the competitiveness of Europe’s markets and economies, and further enhance Europe’s long-term economic growth – two key objectives underpinning the Capital Market Union’s policy platform. The new rule removes friction for companies to attract both European and U.S. investors, benefiting not just our European companies but also providing retail investors with better access to a wider range of investment opportunities.”
Roland Chai, President of Nasdaq European Markets, added: “Reducing obstacles in the listing processes for issuers to access European markets is key to increasing European competitiveness and we are determined to ensure issuers have maximum access to European investors. Nasdaq has been continuously implementing a program of simplification across Nasdaq’s European exchanges, and further market access efficiencies will be rolled out across Nasdaq’s six EU markets. With top rankings in leading tech sectors like medtech, biotech, and renewable energy, as well as delivering annual returns of over eight percent on average over the period 1966-2023, the highest globally, Nasdaq’s Europe’s leadership demonstrates the transformative power of well-executed capital markets integration in the EU.”
For more information regarding the upcoming rulebook changes: https://www.nasdaq.com/market-regulation/nordic/main-market-rules
Nasdaq Media Contact
Erik Gruvfors
+46 73 449 78 12
erik.gruvfors@nasdaq.com
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.
-NDAQG-
- 搜索
-
- 04-11中医药专家于晓津携御君方专家团队出席2025年动脉粥样硬化健康论坛,以临床实证共话中医药科学价值
- 04-11易思脑与汇聚英才成功举行神经回馈训练国际认证助学中心挂牌仪式
- 04-11福城焕新颜 古韵谱华章——金融活水润泽郴州乡村振兴新图景
- 04-11加密货币交易量攀新高 香港券商转型交易量突破百亿居龙头
- 04-11保研录战略收购清华系创业团队“保研印象”,加速清北资源整合与技术创新
- 04-11杜丁副主任医师携御君方全国专家团队亮相2025年动脉粥样硬化健康论坛
- 04-11ProstaVive Reviews (BREAKING REPORT): Must-Read Warnings, Ingredients, Benefits & Real Results U
- 04-11ProstaVive: We Tested It for 90 Days—Our Full Month-by-Month Review and the Shocking Truth About Lon
- 04-11AquaSculpt Reviews (BREAKING): 27,000 CONSUMERS Tracked Over 90 Days—We Finally Have the Answer
- 04-11Bioventra Inc. Reports Surge in Sales of Flagship Wellness Products Mitolyn® and PrimeBiome® in Q1 2